Literature DB >> 14578142

Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup.

Michelle Cotterchio1, Nancy Kreiger, Beth Theis, Margaret Sloan, Saira Bahl.   

Abstract

Evidence suggests hormonal factors may be more strongly associated with estrogen receptor+progesterone receptor+ (ER+PR+) than ER-PR- breast cancer risk. This study evaluated risk factors according to ERPR tumor status among pre- and postmenopausal women participating in two recent population-based case-control studies. Breast cancer cases, ages 25-74 years, and diagnosed 1995-1998 were sampled from the Ontario Cancer Registry. Controls were a random sample of women identified using the Ontario Ministry of Finance rolls and were frequency-matched to cases within 5-year age groups. Epidemiological data were collected from breast cancer cases and controls using two self-administered questionnaires. ERPR data were obtained for 87% of the breast cancer cases (3,276 of 3,748). Multivariate polytomous logistic regression was used to obtain odds ratios estimates and 95% confidence intervals. The following significant differences were observed in the risk factor profiles for ER+PR+ and ER-PR- breast cancer: among premenopausal women, late age at menarche was only associated with a reduction in ER+PR+ breast cancer risk; obesity was associated with an increased ER-PR- and decreased ER+PR+ cancer risk; and the association between alcohol intake and breast cancer risk was heterogeneous across ERPR subgroups, although the direction varied across the levels of alcohol intake. Among postmenopausal women, there were no statistically significant differences observed in the risk factor profiles for ER+PR+ and ER-PR- breast cancer. Some heterogeneity exists in the risk factor profiles of ER+PR+ and ER-PR- premenopausal breast cancer; however, risk factor profiles did not differ markedly for postmenopausal breast cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578142

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  50 in total

1.  Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women.

Authors:  Lynn Rosenberg; Deborah A Boggs; Lauren A Wise; Lucile L Adams-Campbell; Julie R Palmer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies.

Authors:  Xuehong Zhang; Donna Spiegelman; Laura Baglietto; Leslie Bernstein; Deborah A Boggs; Piet A van den Brandt; Julie E Buring; Susan M Gapstur; Graham G Giles; Edward Giovannucci; Gary Goodman; Susan E Hankinson; Kathy J Helzlsouer; Pamela L Horn-Ross; Manami Inoue; Seungyoun Jung; Polyna Khudyakov; Susanna C Larsson; Marie Lof; Marjorie L McCullough; Anthony B Miller; Marian L Neuhouser; Julie R Palmer; Yikyung Park; Kim Robien; Thomas E Rohan; Julie A Ross; Leo J Schouten; James M Shikany; Shoichiro Tsugane; Kala Visvanathan; Elisabete Weiderpass; Alicja Wolk; Walter C Willett; Shumin M Zhang; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  Am J Clin Nutr       Date:  2012-01-25       Impact factor: 7.045

Review 3.  Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.

Authors:  Mark F Munsell; Brian L Sprague; Donald A Berry; Gary Chisholm; Amy Trentham-Dietz
Journal:  Epidemiol Rev       Date:  2014       Impact factor: 6.222

Review 4.  The obesity-inflammation-eicosanoid axis in breast cancer.

Authors:  Linda Vona-Davis; David P Rose
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-30       Impact factor: 2.673

5.  FGFR2 gene polymorphisms are associated with breast cancer risk in the Han Chinese population.

Authors:  Peng Xia; Bin Li; Tingting Geng; Zhiping Deng; Chengxue Dang; Dongmin Chang; Longli Kang; Tianbo Jin; Chao Chen
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

6.  Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data.

Authors:  Saber Fallahpour; Tanya Navaneelan; Prithwish De; Alessia Borgo
Journal:  CMAJ Open       Date:  2017-09-25

7.  A case-control study of oral contraceptive use and incident breast cancer.

Authors:  Lynn Rosenberg; Yuqing Zhang; Patricia F Coogan; Brian L Strom; Julie R Palmer
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

8.  Differential Patterns of Risk Factors for Early-Onset Breast Cancer by ER Status in African American Women.

Authors:  Kimberly A Bertrand; Traci N Bethea; Lucile L Adams-Campbell; Lynn Rosenberg; Julie R Palmer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-10-18       Impact factor: 4.254

9.  Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry.

Authors:  Fang Fang Zhang; Esther M John; Julia A Knight; Manleen Kaur; Mary Daly; Saundra Buys; Irene L Andrulis; Beth Stearman; Dee West; Mary Beth Terry
Journal:  Breast Cancer Res Treat       Date:  2012-12-06       Impact factor: 4.872

10.  Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women.

Authors:  Amanda I Phipps; Kathleen E Malone; Peggy L Porter; Janet R Daling; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07-29       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.